Find Gabapentin Enacarbil manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

KDMF

KDMF

0

VMF

NDC API

API REF. PRICE (USD/KG)

$
$ 0

MARKET PLACE

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

0 DRUGS IN DEVELOPMENT

FDF DossiersDRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

GLOBAL SALES INFORMATION

Annual Reports

NA

Finished Drug Prices

NA

26 RELATED EXCIPIENT COMPANIES

44EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 478296-72-9, Horizant, Regnite, Xp-13512, Solzira, Xp13512
Molecular Formula
C16H27NO6
Molecular Weight
329.39  g/mol
InChI Key
TZDUHAJSIBHXDL-UHFFFAOYSA-N
FDA UNII
75OCL1SPBQ

Gabapentin Enacarbil
Gabapentin enacarbil is marketed under the name Horizant. It is a prodrug of gabapentin, and indicated in adults for the treatment of Restless Legs Syndrome (RLS) and postherpetic neuralgia (PHN).
1 2D Structure

Gabapentin Enacarbil

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
2-[1-[[1-(2-methylpropanoyloxy)ethoxycarbonylamino]methyl]cyclohexyl]acetic acid
2.1.2 InChI
InChI=1S/C16H27NO6/c1-11(2)14(20)22-12(3)23-15(21)17-10-16(9-13(18)19)7-5-4-6-8-16/h11-12H,4-10H2,1-3H3,(H,17,21)(H,18,19)
2.1.3 InChI Key
TZDUHAJSIBHXDL-UHFFFAOYSA-N
2.1.4 Canonical SMILES
CC(C)C(=O)OC(C)OC(=O)NCC1(CCCCC1)CC(=O)O
2.2 Other Identifiers
2.2.1 UNII
75OCL1SPBQ
2.3 Synonyms
2.3.1 MeSH Synonyms

1. 1-(((alpha-isobutanoyloxyethoxy)carbonyl)aminomethyl)-1-cyclohexaneacetic Acid

2. Xp 10569

3. Xp 11084

4. Xp 11239

5. Xp 12464

6. Xp 13512

7. Xp-10569

8. Xp-11084

9. Xp-11239

10. Xp-12464

11. Xp-13512

12. Xp10569

13. Xp11084

14. Xp11239

15. Xp12464

16. Xp13512

2.3.2 Depositor-Supplied Synonyms

1. 478296-72-9

2. Horizant

3. Regnite

4. Xp-13512

5. Solzira

6. Xp13512

7. Asp8825

8. Xp 13512

9. Gsk1838262

10. Asp-8825

11. 75ocl1spbq

12. Gsk-1838262

13. Chebi:68840

14. 2-(1-((((1-(isobutyryloxy)ethoxy)carbonyl)amino)methyl)cyclohexyl)acetic Acid

15. 2-[1-[[1-(2-methylpropanoyloxy)ethoxycarbonylamino]methyl]cyclohexyl]acetic Acid

16. {1-[({[1-(isobutyryloxy)ethoxy]carbonyl}amino)methyl]cyclohexyl}acetic Acid

17. (1-(((((1rs)-1-((2-methylpropanoyl)oxy)ethoxy)carbonyl)amino)methyl)cyclohexyl)acetic Acid

18. (1-{[({(1rs)-1-[isobutyryloxy]ethoxy}carbonyl) Amino]methyl}cyclohexyl)acetic Acid

19. Cyclohexaneacetic Acid, 1-((((1-(2-methyl-1-oxopropoxy)ethoxy)carbonyl)amino)methyl)-

20. Gabapentin Encarbil

21. Unii-75ocl1spbq

22. Gsk 1838262

23. Gabapentin Enacarbil [usan:inn]

24. Gabapentin-encarbil

25. Horizant (tn)

26. Asp 8825

27. Gabapentine Enacarbil

28. Gabapentina Enacarbilo

29. Gabapentinum Enacarbilum

30. Schembl25455

31. Gtpl7560

32. Chembl1628502

33. Gabapentin Encarbil [mi]

34. Dtxsid30870359

35. Gabapentin Enacarbil [inn]

36. Gabapentin Enacarbil [jan]

37. Gabapentin Enacarbil [usan]

38. Bcp12845

39. Gabapentin Enacarbil [vandf]

40. Gabapentin Enacarbil [mart.]

41. Mfcd09954124

42. Xp-053

43. Gabapentin Enacarbil [who-dd]

44. Akos025290727

45. Gabapentin Enacarbil (jan/usan/inn)

46. Cs-1698

47. Db08872

48. Pb32822

49. 1-[[[[1-(2-methyl-1-oxopropoxy)ethoxy]carbonyl]amino]methyl]cyclohexaneacetic Acid

50. Ncgc00532500-01

51. Ac-27644

52. As-35192

53. Gabapentin Enacarbil [orange Book]

54. Hy-16216

55. Db-070861

56. Ft-0753836

57. A20372

58. D09539

59. 296g729

60. Q5515257

61. {[(1-isobutanoyloxyethoxy)carbonyl]aminomethyl}-1-cyclohexane Acetic Acid

62. {[(alpha-isobutanoyloxyethoxy)carbonyl]aminomethyl}-1-cyclohexane Acetic Acid

63. 1-{[(alpha-isobutanovloxyethoxy)carbonyl]aminomethyl}-1-cyclohexane Acetic Acid

64. 1-{[(alpha-isobutanoyloxyethoxy)carbonyl]aminomethyl}-1-cyclohexane Acetic Acid

65. 1-{[(alpha-isobutanoyloxyethoxy)carbonyl]aminomethyl}-1-cyclohexaneacetic Acid

66. 2-[1-[[[1-[(2-methylpropanoyl)oxy]ethoxy]carbonylamino]methyl]cyclohexyl]acetic Acid

2.4 Create Date
2006-10-25
3 Chemical and Physical Properties
Molecular Weight 329.39 g/mol
Molecular Formula C16H27NO6
XLogP33.1
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count6
Rotatable Bond Count9
Exact Mass329.18383758 g/mol
Monoisotopic Mass329.18383758 g/mol
Topological Polar Surface Area102 Ų
Heavy Atom Count23
Formal Charge0
Complexity428
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count1
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Drug and Medication Information
4.1 Drug Information
1 of 2  
Drug NameHorizant
Drug LabelHORIZANT (gabapentin enacarbil) is a prodrug of gabapentin. Gabapentin enacarbil is described as (1-{[({(1RS)-1-[(2-Methylpropanoyl)oxy]ethoxy}carbonyl)amino]methyl} cyclohexyl) acetic acid. It has a molecular formula of C16H27NO6 and a molecular wei...
Active IngredientGabapentin enacarbil
Dosage FormTablet, extended release
RouteOral
Strength600mg; 300mg
Market StatusPrescription
CompanyXenoport

2 of 2  
Drug NameHorizant
Drug LabelHORIZANT (gabapentin enacarbil) is a prodrug of gabapentin. Gabapentin enacarbil is described as (1-{[({(1RS)-1-[(2-Methylpropanoyl)oxy]ethoxy}carbonyl)amino]methyl} cyclohexyl) acetic acid. It has a molecular formula of C16H27NO6 and a molecular wei...
Active IngredientGabapentin enacarbil
Dosage FormTablet, extended release
RouteOral
Strength600mg; 300mg
Market StatusPrescription
CompanyXenoport

4.2 Drug Indication

For the treatment of adult Restless Legs Syndrome (RLS) and postherpetic neuralgia (PHN).


FDA Label


5 Pharmacology and Biochemistry
5.1 Pharmacology

Since gabapentin enacarbil is a prodrug of gabapentin, it's physiological effects are the same as gabapentin. Concerning PHN, gabapentin prevents allodynia and hyperalgesia.


5.2 FDA Pharmacological Classification
5.2.1 Pharmacological Classes
Decreased Central Nervous System Disorganized Electrical Activity [PE]; Anti-epileptic Agent [EPC]
5.3 Absorption, Distribution and Excretion

Absorption

Gabapentin enacarbil is absorbed in the intestines by active transport through the proton-linked monocarboxylate transporter, MCT-1.


Route of Elimination

Gabapentin enacarbil is eliminated primarily in the urine (94%) and to a lesser extent in the feces (5%).


Volume of Distribution

The volume of distribution is 76L.


Clearance

Renal clearance of gabapentin is 5 to 7 L/hr.


5.4 Metabolism/Metabolites

Gabapentin enacarbil does not interact with any of the major cytochrome P450 enzymes.


5.5 Biological Half-Life

The elimination half-life of gabapentin is 5.1 to 6.0 hours.


5.6 Mechanism of Action

Although the exact mechanism of action of gabapentin in RLS and PHN is unknown, it is presumed to involve the descending noradrenergic system, resulting in the activation of spinal alpha2-adrenergic receptors.


API SUPPLIERS

read-more
read-more

01

Atman Pharmaceuticals

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
Duphat
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothAtman Pharmaceuticals: A One Stop Solution Provider to All Your API Needs.

Flag India
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
Atman Pharmaceuticals

02

Aurobindo Pharma Limited

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Duphat
Not Confirmed
arrow

Aurobindo Pharma Limited

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
Duphat
Not Confirmed
USDMF arrow-down CEP/COS JDMF EU-WC NDC arrow-down KDMF VMF Others AUDIT
blank

03

Dasami Lab

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Duphat
Not Confirmed
arrow

Dasami Lab

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
Duphat
Not Confirmed
USDMF arrow-down CEP/COS JDMF EU-WC NDC arrow-down KDMF VMF Others AUDIT
blank

04

Glenmark Life Sciences

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Duphat
Not Confirmed
arrow

Glenmark Life Sciences

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
Duphat
Not Confirmed
USDMF arrow-down CEP/COS JDMF EU-WCarrow-down NDC arrow-down KDMF VMF Others AUDIT
blank

05

Maps Laboratories Private Limited

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Duphat
Not Confirmed
arrow

Maps Laboratories Private Limited

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
Duphat
Not Confirmed
USDMF CEP/COS JDMF EU-WCarrow-down NDC KDMF VMF Others AUDIT
blank

06

Glenmark Pharmaceuticals

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Duphat
Not Confirmed
arrow

07

Zhejiang Bamboo Pharmaceuticals

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Duphat
Not Confirmed
arrow

08

Maithri Drugs

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Duphat
Not Confirmed
arrow

09

Hetero Drugs

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Duphat
Not Confirmed
arrow

Hetero Drugs

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
Duphat
Not Confirmed
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

10

Rakshit Drugs

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Duphat
Not Confirmed
arrow

Rakshit Drugs

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
Duphat
Not Confirmed
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

USDMF

read-more
read-more

01

Duphat
Not Confirmed

01

02

Duphat
Not Confirmed

02

Duphat
Not Confirmed

GDUFA

DMF Review : Complete

Rev. Date : 2019-05-10

Pay. Date : 2019-02-21

DMF Number : 33386

Submission : 2019-03-29

Status : Active

Type : II

blank

03

Duphat
Not Confirmed

03

Duphat
Not Confirmed

GDUFA

DMF Review : Complete

Rev. Date : 2018-11-21

Pay. Date : 2018-11-02

DMF Number : 33296

Submission : 2018-11-02

Status : Active

Type : II

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Listed Suppliers

read-more
read-more

01

arrow
Duphat
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothAtman Pharmaceuticals: A One Stop Solution Provider to All Your API Needs.

Flag India
Digital Content Digital Content

Gabapentin Enacarbil

About the Company : Atman Pharmaceuticals is a fully integrated pharmaceutical company that has distinguished itself as a leader in Bulk Drugs (API) marketing both domestically in India and overseas. ...

Atman Pharmaceuticals is a fully integrated pharmaceutical company that has distinguished itself as a leader in Bulk Drugs (API) marketing both domestically in India and overseas. With a heritage spanning over 33 years and vast experience, we have earned a reputation for delivering high-quality and abundant services within the industry. Our emergence as prominent solution providers in the pharmaceutical business underscores our commitment to excellence.
Atman Pharmaceuticals

02

Duphat
Not Confirmed
arrow
arrow
Duphat
Not Confirmed

Gabapentin Enacarbil

About the Company : Founded in 1986 by Mr. P.V. Ramaprasad Reddy, Mr. K. Nityananda Reddy and a small group of highly committed professionals, Aurobindo Pharma was born off a vision. The company comme...

Founded in 1986 by Mr. P.V. Ramaprasad Reddy, Mr. K. Nityananda Reddy and a small group of highly committed professionals, Aurobindo Pharma was born off a vision. The company commenced operations in 1988-89 with a single unit manufacturing Semi-Synthetic Penicillin (SSP) at Pondicherry. Aurobindo Pharma became a public company in 1992 and listed its shares in the Indian stock exchanges in 1995. In addition to being the market leader in Semi-Synthetic Penicillins, it has a presence in key therapeutic segments such as neurosciences, cardiovascular, anti-retrovirals, anti-diabetics, gastroenterology and cephalosporins, among others.
blank

03

Dasami Lab

India
Duphat
Not Confirmed
arrow

Dasami Lab

India
arrow
Duphat
Not Confirmed

Gabapentin Enacarbil

About the Company : Dasami Lab Private Limited incorporated with MCA on 24 July 2015. The Dasami Lab Private Limited is listed in the class of pvtltd company and classified as Non Govt Company. This c...

Dasami Lab Private Limited incorporated with MCA on 24 July 2015. The Dasami Lab Private Limited is listed in the class of pvtltd company and classified as Non Govt Company. This company is registered at Registrar of Companies(ROC), Hyderabad with an Authorized Share Capital of Rs. 110 CR and its paid up capital is 110 CR.
blank

04

Duphat
Not Confirmed
arrow
arrow
Duphat
Not Confirmed

Gabapentin Enacarbil

About the Company : Glenmark was founded with a vision to emerge as a leading integrated research-based, global pharmaceutical company. Our branded generics business has a significant presence in mark...

Glenmark was founded with a vision to emerge as a leading integrated research-based, global pharmaceutical company. Our branded generics business has a significant presence in markets across emerging economies including India. The generics business services the requirements of developed markets like US and Western Europe. Our API business sells products in over 65 countries including the US, various countries in the EU, South America and India. With 15 manufacturing facilities and 3 R&D centers dedicated to the goal of enriching lives across the globe.
blank

05

Hetero Drugs

India
Duphat
Not Confirmed
arrow

Hetero Drugs

India
arrow
Duphat
Not Confirmed

Gabapentin Enacarbil

About the Company : Hetero is a research based global pharmaceutical company focused on development, manufacturing and marketing of Active Pharmaceutical Ingredients (APIs), Intermediate Chemicals & F...

Hetero is a research based global pharmaceutical company focused on development, manufacturing and marketing of Active Pharmaceutical Ingredients (APIs), Intermediate Chemicals & Finished Dosages. Ever since its establishment in 1993, Hetero showed a tradition of excellence and deep sense of commitment in developing cost effective processes to offer wide range of affordable drugs. Hetero is building on the strengths of vertical integration in discovery research, process chemistry, API manufacturing, formulation development and commercialization.
blank

06

Duphat
Not Confirmed
arrow
arrow
Duphat
Not Confirmed

Gabapentin Enacarbil

About the Company : Maithri Drugs is one of India's fast-growing pharmaceutical companies. Maithri's strategic focus is on active pharma ingredients (APIs). The company is widely recognized for its ex...

Maithri Drugs is one of India's fast-growing pharmaceutical companies. Maithri's strategic focus is on active pharma ingredients (APIs). The company is widely recognized for its excellent research & development and aggressive growth strategies. Our 32 US DMFs and 9 CEPs in a short span attest to our R&D excellence. Maithri's manufacturing facility is located in Hyderabad. This facility is audited and approved by the US FDA. In addition, our facility is certified according to the standards of DCGI, WHO GMP, and ISO 9001:2015 We have a portfolio of 65 products and are continually expanding.
blank

07

Duphat
Not Confirmed
arrow
arrow
Duphat
Not Confirmed

Gabapentin Enacarbil

About the Company : Rakshit is an integrated API manufacturing company. Established in 2000. Today Rakshit has emerged a dependable and strong manufacturer of key APIs & intermediates for global marke...

Rakshit is an integrated API manufacturing company. Established in 2000. Today Rakshit has emerged a dependable and strong manufacturer of key APIs & intermediates for global markets. Focusing on its activities in R&D as well as building up newer facilities/ capacities to catch up with increasing demand year after year. Rakshit group has 4 cGMP compliance Manufacturing Facilities spread over Andhra Pradesh & Telangana states of India. Supplying its products to all over the globe from US, Europe, Japan, Asia & to Latin America. Rakshit facilities are approved by the regulatory authorities like, USFDA, Japan PMDA, Korea-MFDS, CDSCO-India.
blank

08

Duphat
Not Confirmed
arrow
arrow
Duphat
Not Confirmed

Gabapentin Enacarbil

About the Company : Zhejiang Bamboo Pharmaceuticals is a new, innovative, green, high-grade pharmaceutical intermediate, API and oral solid formulation pharmaceutical manufacturer which was establishe...

Zhejiang Bamboo Pharmaceuticals is a new, innovative, green, high-grade pharmaceutical intermediate, API and oral solid formulation pharmaceutical manufacturer which was established in 2020. The company is positioned as a modern and regulatory pharmaceutical company with API and formulation drug. The formulation drug are mainly sold to the domestic market, and the goal is to become one of the largest supplier of Chinese "4 + 7" volume procurement in China.
blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

FDF Dossiers

read-more
read-more

01

Duphat
Not Confirmed
arrow
arrow
Duphat
Not Confirmed

GABAPENTIN ENACARBIL

Brand Name : HORIZANT

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : 600MG

Packaging :

Approval Date : 2011-04-06

Application Number : 22399

Regulatory Info : RX

Registration Country : USA

blank

02

Duphat
Not Confirmed
arrow
arrow
Duphat
Not Confirmed

GABAPENTIN ENACARBIL

Brand Name : HORIZANT

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : 300MG

Packaging :

Approval Date : 2011-12-13

Application Number : 22399

Regulatory Info : RX

Registration Country : USA

blank

03

Duphat
Not Confirmed
arrow
arrow
Duphat
Not Confirmed

GABAPENTIN ENCARBIL

Brand Name : GABAPENTIN ENCARBIL

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : 300MG

Packaging :

Approval Date :

Application Number : 213501

Regulatory Info :

Registration Country : USA

blank

04

Duphat
Not Confirmed
arrow
arrow
Duphat
Not Confirmed

GABAPENTIN ENCARBIL

Brand Name : GABAPENTIN ENCARBIL

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : 600MG

Packaging :

Approval Date :

Application Number : 213501

Regulatory Info :

Registration Country : USA

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

FDA Orange Book

read-more
read-more

01

AZURITY

U.S.A
Duphat
Not Confirmed
arrow

AZURITY

U.S.A
arrow
Duphat
Not Confirmed

GABAPENTIN ENACARBIL

Brand Name : HORIZANT

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : 600MG

Approval Date : 2011-04-06

Application Number : 22399

RX/OTC/DISCN : RX

RLD : Yes

TE Code :

blank

02

AZURITY

U.S.A
Duphat
Not Confirmed
arrow

AZURITY

U.S.A
arrow
Duphat
Not Confirmed

GABAPENTIN ENACARBIL

Brand Name : HORIZANT

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : 300MG

Approval Date : 2011-12-13

Application Number : 22399

RX/OTC/DISCN : RX

RLD : Yes

TE Code :

blank

03

Duphat
Not Confirmed
arrow
arrow
Duphat
Not Confirmed

GABAPENTIN ENCARBIL

Brand Name : GABAPENTIN ENCARBIL

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : 300MG

Approval Date :

Application Number : 213501

RX/OTC/DISCN :

RLD :

TE Code :

blank

04

Duphat
Not Confirmed
arrow
arrow
Duphat
Not Confirmed

GABAPENTIN ENCARBIL

Brand Name : GABAPENTIN ENCARBIL

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : 600MG

Approval Date :

Application Number : 213501

RX/OTC/DISCN :

RLD :

TE Code :

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

DRUG PRODUCT COMPOSITIONS

Do you need Business Intel? Ask us

DOSAGE - TABLET, EXTENDED RELEASE;ORAL - 300M...DOSAGE - TABLET, EXTENDED RELEASE;ORAL - 300MG

USFDA APPLICATION NUMBER - 22399

read-more

DOSAGE - TABLET, EXTENDED RELEASE;ORAL - 600M...DOSAGE - TABLET, EXTENDED RELEASE;ORAL - 600MG

USFDA APPLICATION NUMBER - 22399

read-more

Related Excipient Companies

Upload your portfolio for free, ask us

Excipients by Applications

Click here to find the perfect excipient manufacturers by their capabilities

Lubricants & Glidants

read-more
read-more

Fillers, Diluents & Binders

read-more
read-more

Granulation

read-more
read-more

Direct Compression

read-more
read-more

Coating Systems & Additives

read-more
read-more

Emulsifying Agents

read-more
read-more

Controlled & Modified Release

read-more
read-more

Taste Masking

read-more
read-more

Thickeners and Stabilizers

read-more
read-more

Film Formers & Plasticizers

read-more
read-more

Co-Processed Excipients

read-more
read-more

Surfactant & Foaming Agents

read-more
read-more

API Stability Enhancers

read-more
read-more

Topical

read-more
read-more

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

Global Sales Information

Do you need Business Intel? Ask us

US Medicaid Prescriptions

read-more
read-more

01

arrow
Duphat
Not Confirmed
arrow
Duphat
Not Confirmed

Company :

Gabapentin Enacarbil

Drug Cost (USD) : 33,507,494

Year : 2022

Prescribers : 6767

Prescriptions : 34193

blank

02

arrow
Duphat
Not Confirmed
arrow
Duphat
Not Confirmed

Company :

Gabapentin Enacarbil

Drug Cost (USD) : 32,575,765

Year : 2021

Prescribers : 7511

Prescriptions : 35141

blank

03

arrow
Duphat
Not Confirmed
arrow
Duphat
Not Confirmed

Company :

Gabapentin Enacarbil

Drug Cost (USD) : 29,899,246

Year : 2020

Prescribers : 7029

Prescriptions : 34960

blank

04

arrow
Duphat
Not Confirmed
arrow
Duphat
Not Confirmed

Company :

Gabapentin Enacarbil

Drug Cost (USD) : 26,705,623

Year : 2019

Prescribers : 7426

Prescriptions : 34651

blank

05

arrow
Duphat
Not Confirmed
arrow
Duphat
Not Confirmed

Company :

Gabapentin Enacarbil

Drug Cost (USD) : 24,284,718

Year : 2018

Prescribers : 7280

Prescriptions : 32598

blank

06

arrow
Duphat
Not Confirmed
arrow
Duphat
Not Confirmed

Company :

Gabapentin Enacarbil

Drug Cost (USD) : 21,378,147

Year : 2017

Prescribers : 7052

Prescriptions : 30120

blank

07

arrow
Duphat
Not Confirmed
arrow
Duphat
Not Confirmed

Company :

Gabapentin Enacarbil

Drug Cost (USD) : 17,191,343

Year : 2016

Prescribers : 7057

Prescriptions : 28650

blank

08

arrow
Duphat
Not Confirmed
arrow
Duphat
Not Confirmed

Company :

Gabapentin Enacarbil

Drug Cost (USD) : 9,712,356

Year : 2015

Prescribers : 5658

Prescriptions : 20846

blank

09

arrow
Duphat
Not Confirmed
arrow
Duphat
Not Confirmed

Company :

GABAPENTIN ENACARBIL

Drug Cost (USD) : 5,113,480

Year : 2014

Prescribers : 4298

Prescriptions : 15392

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Market Place

Do you need sourcing support? Ask us

Patents & EXCLUSIVITIES

Check the patents & exclusivity for this product

ABOUT THIS PAGE

Gabapentin Enacarbil Manufacturers

A Gabapentin Enacarbil manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Gabapentin Enacarbil, including repackagers and relabelers. The FDA regulates Gabapentin Enacarbil manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Gabapentin Enacarbil API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Gabapentin Enacarbil manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Gabapentin Enacarbil Suppliers

A Gabapentin Enacarbil supplier is an individual or a company that provides Gabapentin Enacarbil active pharmaceutical ingredient (API) or Gabapentin Enacarbil finished formulations upon request. The Gabapentin Enacarbil suppliers may include Gabapentin Enacarbil API manufacturers, exporters, distributors and traders.

click here to find a list of Gabapentin Enacarbil suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Gabapentin Enacarbil USDMF

A Gabapentin Enacarbil DMF (Drug Master File) is a document detailing the whole manufacturing process of Gabapentin Enacarbil active pharmaceutical ingredient (API) in detail. Different forms of Gabapentin Enacarbil DMFs exist exist since differing nations have different regulations, such as Gabapentin Enacarbil USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A Gabapentin Enacarbil DMF submitted to regulatory agencies in the US is known as a USDMF. Gabapentin Enacarbil USDMF includes data on Gabapentin Enacarbil's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Gabapentin Enacarbil USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of Gabapentin Enacarbil suppliers with USDMF on PharmaCompass.

Gabapentin Enacarbil WC

A Gabapentin Enacarbil written confirmation (Gabapentin Enacarbil WC) is an official document issued by a regulatory agency to a Gabapentin Enacarbil manufacturer, verifying that the manufacturing facility of a Gabapentin Enacarbil active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Gabapentin Enacarbil APIs or Gabapentin Enacarbil finished pharmaceutical products to another nation, regulatory agencies frequently require a Gabapentin Enacarbil WC (written confirmation) as part of the regulatory process.

click here to find a list of Gabapentin Enacarbil suppliers with Written Confirmation (WC) on PharmaCompass.

Gabapentin Enacarbil NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Gabapentin Enacarbil as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Gabapentin Enacarbil API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Gabapentin Enacarbil as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Gabapentin Enacarbil and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Gabapentin Enacarbil NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Gabapentin Enacarbil suppliers with NDC on PharmaCompass.

Gabapentin Enacarbil GMP

Gabapentin Enacarbil Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Gabapentin Enacarbil GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Gabapentin Enacarbil GMP manufacturer or Gabapentin Enacarbil GMP API supplier for your needs.

Gabapentin Enacarbil CoA

A Gabapentin Enacarbil CoA (Certificate of Analysis) is a formal document that attests to Gabapentin Enacarbil's compliance with Gabapentin Enacarbil specifications and serves as a tool for batch-level quality control.

Gabapentin Enacarbil CoA mostly includes findings from lab analyses of a specific batch. For each Gabapentin Enacarbil CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Gabapentin Enacarbil may be tested according to a variety of international standards, such as European Pharmacopoeia (Gabapentin Enacarbil EP), Gabapentin Enacarbil JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Gabapentin Enacarbil USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty